Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-20 9:36 pm Sale | 2024-11-18 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 1,370,841 4.990% | -375,833 (-21.52%) | Filing History |
| 2024-11-15 4:39 pm Purchase | 2024-11-13 | 13D | OPKO Health, Inc. OPK | FROST PHILLIP MD | 250,460,363 37.100% | 380,183 (+0.15%) | Filing History |
| 2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | OPKO Health, Inc. OPK | Rubric Capital Management LP | 48,706,640 6.980% | 48,706,640 (New Position) | Filing History |
| 2024-11-12 4:54 pm Unchanged | 2024-09-30 | 13G | OPKO Health, Inc. OPK | VANGUARD GROUP INC | 29,218,150 4.180% | 0 (Unchanged) | Filing History |
| 2024-11-08 5:23 pm Sale | 2024-11-06 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 1,746,674 6.360% | -425,000 (-19.57%) | Filing History |
| 2024-11-04 1:24 pm Sale | 2024-09-30 | 13G | OPKO Health, Inc. OPK | VANGUARD GROUP INC | 29,218,150 4.180% | -10,533,143 (-26.50%) | Filing History |
| 2024-09-18 4:13 pm Sale | 2024-09-16 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 2,171,674 8.060% | -330,472 (-13.21%) | Filing History |
| 2024-08-29 4:10 pm Purchase | 2024-08-27 | 13D | OPKO Health, Inc. OPK | FROST PHILLIP MD | 250,080,180 36.000% | 5,376,497 (+2.20%) | Filing History |
| 2024-08-23 5:33 pm Sale | 2024-08-22 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 2,502,146 9.290% | -309,637 (-11.01%) | Filing History |
| 2024-08-12 6:27 pm Sale | 2024-08-08 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 2,811,783 10.440% | -311,620 (-9.98%) | Filing History |
| 2024-07-26 7:43 pm Sale | 2024-07-24 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 3,123,403 11.940% | -346,118 (-9.98%) | Filing History |
| 2024-07-05 4:14 pm Purchase | 2024-07-03 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 3,469,521 13.270% | 3,469,521 (New Position) | Filing History |
| 2024-02-13 5:12 pm Sale | 2023-12-29 | 13G | OPKO Health, Inc. OPK | VANGUARD GROUP INC | 39,751,293 5.140% | -1,369,201 (-3.33%) | Filing History |
| 2024-01-24 4:15 pm Sale | 2024-01-22 | 13D | OPKO Health, Inc. OPK | HSIAO JANE PH D | 35,777,284 5.110% | -199,990 (-0.56%) | Filing History |
| 2024-01-24 4:01 pm Unchanged | 2024-01-22 | 13D | OPKO Health, Inc. OPK | FROST PHILLIP MD | 244,703,683 35.000% | 0 (Unchanged) | Filing History |
| 2024-01-22 4:26 pm Sale | 2024-01-18 | 13D | OPKO Health, Inc. OPK | FROST PHILLIP MD | 244,703,683 33.900% | -7,723,710 (-3.06%) | Filing History |
| 2023-04-20 4:26 pm Purchase | 2023-04-12 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 3,558,602 14.300% | 701,459 (+24.55%) | Filing History |
| 2023-02-21 4:20 pm Purchase | 2023-02-10 | 13D | OPKO Health, Inc. OPK | FROST PHILLIP MD | 252,427,393 31.900% | 11,835,241 (+4.92%) | Filing History |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | OPKO Health, Inc. OPK | VANGUARD GROUP INC | 41,120,494 5.320% | 5,395,070 (+15.10%) | Filing History |
| 2023-02-03 4:10 pm Purchase | 2023-01-26 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 2,857,143 11.600% | 432,900 (+17.86%) | Filing History |